Skip to main content

Founder Profile

Hans Christian Hagedorn

Last reviewed: October 2026 · By Swet Parvadiya

Who is Hans Christian Hagedorn?

Hans Christian Hagedorn is a founder of Novo Nordisk A/S, which was founded in 1989 with Harald Pedersen.

Company founded
Novo Nordisk A/S
Founded
1989
Co-founders
Harald Pedersen

Background

Hans Christian Hagedorn was a pioneering Danish physician who co-founded the Nordisk Insulinlaboratorium in 1923. His defining moment was the development of the first prolonged-acting insulin formulations, which transformed insulin from a life-saving but short-acting emergency treatment into a manageable chronic therapy. This decision established the company's long-term philosophy of focusing on peptide chemistry and formulation science to improve patient compliance.

Founding Story

Hans Christian Hagedorn (1888-1971) was a Danish physician who co-founded Nordisk Insulinlaboratorium in 1923 with August and Marie Krogh after the Kroghs obtained rights to make insulin in Scandinavia. In 1936 he showed that adding protamine slowed insulin absorption, which led to NPH (Neutral Protamine Hagedorn) insulin, a long-acting insulin still used today. Nordisk merged with rival Novo in 1989 to form Novo Nordisk. (Exact birth year remains publicly undisclosed).

Sources

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.